QA: RespireRx Pharmaceuticals Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000849636_2021_RespireRx_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000849636')"}

Graph

Absolute values for 0000849636, RespireRx Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 85,087
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 8,148,407
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,676,860
9 ResearchAndDevelopmentExpense 638,275
10 remainder_Expenses 545,675
11 remainder_Revenues 0
12 remainder_NetIncome -440,401
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 85,087
1 Liabilities 8,148,407
2 Expenses 3,860,810
3 Revenues 0
4 StockholdersEquity -8,063,320
5 NetIncome -4,301,211
6 ComprehensiveNetIncome -4,301,211
7 BaseVar 6,267,352
8 EconomicCapitalRatio -4.41

Edgar->Model Mapping

Feature Distribution

Change over Time